Mark Jit

Mark Jit is professor and inaugural chair of the Department of Global and Environmental Health at the School of Global Public Health, New York University. Previously, he headed the Department of Infectious Disease Epidemiology & Dynamics at the London School of Hygiene & Tropical Medicine. He continues to hold an honorary professorship there, as well as at the University of Hong Kong and the National University of Singapore. He also worked for many years on vaccine modelling and economics at the UK Health Security Agency and its predecessors Public Health England and the Health Protection Agency.  

Mark's research focuses on epidemiological and economic modelling of vaccines to inform evidence-based public health decision making. His work has covered a range of antigens for current and pipeline vaccines including those against measles, HPV, pneumococcus, rotavirus, influenza, dengue, EV71, RSV, GBS and COVID-19, as well as methodological papers advancing the ways vaccines are evaluated. He has been a member of the WHO's Product Development of Vaccines Advisory Committee (PDVAC) and Immunization and vaccines related implementation research advisory committee (IVIR-AC). He also co-chaired the Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases. He organises or contributes to courses on infectious disease modelling, health economics, vaccinology and health decision science around the world.